editor.ajphr@gmail.com
9409046853
e-ISSN: 2321-3647
logo

American Journal of Pharmacy and Health Research

📢 Latest Update: Call for Papers for a Peer Reviewed Open Access Pharmacy Journal with Fast Publication

📢 Latest Update: Call for Papers for a Peer Reviewed Open Access Pharmacy Journal with Fast Publication

Volume 12, Issue 8 - 2024 (August 2024 Issue 08)

Volume 12 Issue 8 Cover

Issue Details:

Volume 12 Issue 8
Published:Invalid Date

Editorial: August 2024 Issue 08

Welcome to the 2024 issue of American Journal of Pharmacy and Health Research. This issue showcases the remarkable breadth and depth of contemporary research across multiple disciplines. From cutting-edge applications of machine learning in climate science to the revolutionary potential of quantum computing in drug discovery, our featured articles demonstrate the power of interdisciplinary collaboration in addressing global challenges.

We are particularly excited to present research that bridges traditional academic boundaries, reflecting our journal's commitment to fostering innovation through cross-disciplinary dialogue. The integration of artificial intelligence with environmental science, the application of blockchain technology to supply chain management, and the convergence of urban planning with smart city technologies exemplify the transformative potential of collaborative research.

As we continue to navigate an era of rapid technological advancement and global challenges, the research presented in this issue offers both insights and solutions that will shape our future. We thank our authors, reviewers, and editorial board members for their continued dedication to advancing knowledge and promoting scientific excellence.

Dr H J Patel
Editor-in-Chief
American Journal of Pharmacy and Health Research

Articles in This Issue

Showing 1 of 1 articles
Research PaperID: AJPHR1208001

Risk Factors on Covid-19 Drugs

Kunchala Malleswari, Desireddy.Rama Bramha Reddy, Mogilli.Lakshmi Parvathi, Gangavarapu Sowmya Sri, Pichuka Harika

ABSTRACTTo increase the success in Covid 19 treatment, many drug suggestions are presented, and some clinical studies to are shared in the literature. There have been some attempts to use some of these drugs in combination. However, using more than one drug together may cause serious side effects on patients. Therefore, detecting drug-drug interactions of the drugs used will be of great importance in the treatment of Covid 19. In this study, the interactions of 8 drugs used for Covid 19 treatment with 645 different drugs and possible side effects estimates have been produced using Graph Convolutional Networks. As a result of the experiments, it has been found that the hematopoietic system and the cardiovascular system are exposed to more side effects than other organs. Among the focused drugs, Heparin and Atazanavir appear to cause more adverse reactions than other drugs. In addition, as it is known that some of these 8 drugs are used together in Covid-19 treatment, the side effects caused by using these drugs together are shared. With the experimental result obtained, it is aimed to facilitate the selection of the drugs and increase the success of Covid 19 treatment according to the targeted patient. In this review, we conclude some AEs of vitamin-D, zinc, Remdesivir, Hydroxychloroquine or chloroquine, azithromycin, dexamethasone, amantadine, aspirin reported in different papers and we continue the rest of the drugs in second part of our review article. Keywords: Mechanism, Treatment, Side effects of covid -19 drugs

MechanismTreatmentSide effects of covid -19 drugs
108,883 views
32,586 downloads

Contributors:

 Kunchala Malleswari
,
 Desireddy.Rama Bramha Reddy
,
 Mogilli.Lakshmi Parvathi
,
 Gangavarapu Sowmya Sri
,
 Pichuka Harika
Whatsapp